Why Viveve Medical Inc. [VIVE] Stock Can Run Back to New Highs Quicker Than You Think

Over the past three months, Viveve Medical Inc. [VIVE] ended the trading day at $4.90 and exhibited a change of 2.08% with a 24 hour trading and reached upto the volume of 88.60K compared to its recorded trading volume of 0.82 million. VIVE generated a 1 year amount change with -48.40%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by -14.29% with an amount shift of 2.67% over the last month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


On 3, December 2020, Viveve Announces FDA 510K Approval to Expand Manufacturing of Treatment Tips. According to news published on Yahoo Finance, Approval strengthens supply chain and reduces manufacturing costs for consumable component used with Viveve’s Cryogen-cooled Monopolar Radiofrequency technology.

Analyst Birdseye View:

The most recent analyst activity for Viveve Medical Inc. [NASDAQ:VIVE] stock was on July 23, 2019, when it was Downgrade with a Mkt perform rating from Raymond James. Before that, on July 23, 2019, Stifel Recapitulated a Hold rating and elevated its amount target to $1. On July 23, 2019, Maxim Group Downgrade a Hold rating. On April 17, 2018, Stifel Initiated a Buy rating and increased its price target to $6. On January 05, 2018, Northland Capital Initiated an Outperform rating and increased its price target to $8. On November 17, 2017, Mizuho Initiated a Buy rating and boosted its amount on this stock to $10. On May 25, 2017, Raymond James Initiated an Outperform rating.

In the past 52 weeks of trading, this stock has oscillated between a low of $4.14 and a peak of $20.90. Right now, the middling Wall Street analyst 12-month amount mark is $22.00. At the most recent market close, shares of Viveve Medical Inc. [NASDAQ:VIVE] were valued at $4.90.


Viveve Medical Inc. [NASDAQ:VIVE] most recently reported quarterly sales of 1.52 billion, which represented growth of 36.40%. This publicly-traded organization’s revenue is $119,400 per employee, while its income is -$773,200 per employee. This company’s Gross Margin is currently -1.40%, its Pretax Margin is -638.02, and its Net Margin is -647.57. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -115.23, -396.83, -106.27 and -151.67 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 20.97 and the whole liability to whole assets at 16.25. It shows enduring liability to the whole principal at 19.69 and enduring liability to assets at 0.15 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 4.27 points at 1st support level, the second support level is making up to 3.75. But as of 1st resistance point, this stock is sitting at 5.19 and at 5.59 for 2nd resistance point.

Viveve Medical Inc. [VIVE] reported its earnings at -$2.6 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$5.3/share signifying the difference of 2.7 and 50.90% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$5.7 calling estimates for -$5.9/share with the difference of 0.2 depicting the surprise of 3.40%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Viveve Medical Inc. [NASDAQ:VIVE] is 4.90. Likewise, the Quick ratio is also the same, showing Cash ratio at 2.11. Now if looking for a valuation of this stock’s amount to sales ratio it’s 0.24 and it’s amount to book ratio is 0.54.